Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 91.72B | 89.45B | 79.74B | 79.71B | 72.85B | 58.38B |
Gross Profit | 47.23B | 45.84B | 40.45B | 39.29B | 37.19B | 31.31B |
EBITDA | 27.03B | 26.72B | 23.46B | 23.08B | 22.87B | 20.77B |
Net Income | 14.75B | 14.44B | 14.50B | 14.46B | 12.67B | 11.38B |
Balance Sheet | ||||||
Total Assets | 142.16B | 162.51B | 132.64B | 137.96B | 138.60B | 125.20B |
Cash, Cash Equivalents and Short-Term Investments | 17.52B | 29.84B | 16.34B | 15.38B | 18.54B | 18.79B |
Total Debt | 3.16B | 3.45B | 3.50B | 3.85B | 3.10B | 4.79B |
Total Liabilities | 48.95B | 62.93B | 52.50B | 54.63B | 54.58B | 50.05B |
Stockholders Equity | 92.47B | 98.64B | 78.97B | 81.96B | 82.64B | 73.82B |
Cash Flow | ||||||
Free Cash Flow | 21.66B | 21.35B | 18.71B | 14.11B | 15.22B | 14.16B |
Operating Cash Flow | 26.28B | 26.10B | 24.71B | 20.64B | 22.90B | 18.86B |
Investing Cash Flow | -4.35B | -5.46B | -5.77B | -5.00B | -7.73B | -6.80B |
Financing Cash Flow | -19.14B | -10.35B | -16.12B | -16.34B | -16.04B | -8.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $2.31B | 14.89 | 10.15% | 3.60% | 13.92% | 32.69% | |
72 Outperform | $121.95B | 17.05 | 8.97% | 1.70% | -2.06% | 21.03% | |
71 Outperform | $35.13B | 13.36 | 15.08% | 2.07% | -0.79% | -10.83% | |
67 Neutral | $17.54B | 31.28 | 6.88% | 5.29% | -2.73% | -37.93% | |
67 Neutral | $10.18B | 10.13 | 7.79% | 3.56% | -5.48% | -6.99% | |
66 Neutral | £7.72B | 8.36 | 7.55% | 3.50% | 2.08% | 24.83% | |
60 Neutral | $29.66B | 49.10 | -5.05% | 2.44% | -0.47% | -117.62% |